MDPI and ACS Style
Levidou, G.; Gajdzis, P.; Cassoux, N.; Donizy, P.; Masaoutis, C.; Gajdzis, M.; Gardrat, S.; Pergaris, A.; Danas, E.; Klijanienko, J.;
et al. Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients’ Survival. Cancers 2021, 13, 4763.
https://doi.org/10.3390/cancers13194763
AMA Style
Levidou G, Gajdzis P, Cassoux N, Donizy P, Masaoutis C, Gajdzis M, Gardrat S, Pergaris A, Danas E, Klijanienko J,
et al. Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients’ Survival. Cancers. 2021; 13(19):4763.
https://doi.org/10.3390/cancers13194763
Chicago/Turabian Style
Levidou, Georgia, Pawel Gajdzis, Nathalie Cassoux, Piotr Donizy, Christos Masaoutis, Malgorzata Gajdzis, Sophie Gardrat, Alexandros Pergaris, Eougken Danas, Jerzy Klijanienko,
and et al. 2021. "Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients’ Survival" Cancers 13, no. 19: 4763.
https://doi.org/10.3390/cancers13194763